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Abstract Advances in DNA sequencing technology pro-
vide the possibility to analyse and characterize the genetic
material from microbial populations (the microbiome) as a
whole. Such comprehensive analysis of a microbiome using
these ‘metagenomic’ approaches offers the potential to
understand industrial, clinical and environmental microbi-
ology to a level of detail that is unfeasible using
conventional molecular or culture-based methods. However,
the complexity offered by metagenomic analysis is also the
weakness of this method and poses considerable challenges
during analytical standardisation. In this manuscript, we
discuss options for developing control materials for me-
tagenomic analysis and describe our preliminary work
investigating how such materials can be used to assist me-
tagenomic measurements. The control materials we have
developed demonstrate that, when performing 16S rDNA
sequencing, different library preparation methods (incorpo-
rating adapters before and after the PCR) and small primer
mismatches can alter the reported metagenomic profile.
These findings illustrate that metagenomic analysis can be
heavily biased by the choice of method and underpin the
need for control materials that can provide a useful tool in
informing choice of protocol for accurate analysis.
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Introduction
A metagenome can be defined as the genetic material present
within an environmental sample. The term environment in
this context refers not only to the classic outdoor terrestrial
[1] and aquatic [2, 3] domains, but also environments found
within other organisms, like the gut [4, 5] and associated
matrices like probiotic supplements [6] or linked to other
man-made scenarios like water purification [7] or during
fermentation [8]. The field of metagenome analysis
(metagenomics) has grown rapidly as the last 10 years have
seen the development and establishment of next generation
(also termed massively parallel) sequencing (NGS), a tech-
nique that has the potential to read over a billion sequences in
a single run. By combining the power of NGS with microbial
population analysis, metagenomics offers huge potential to
enable us to understand environmental, industrial and clinical
microbiology. By capturing a large proportion of the genetic
material, the microbiome can be analysed as the complex
population of component organisms present in vivo. This has
the potential to offer a considerable breakthrough when
compared to existing molecular and culture-based methods
that typically focus on individual species or small groups of
organisms. There are a number of studies that have already
illustrated the power of metagenomics with the Sorcerer II
Global Ocean Sampling Expedition [3] and Human
Microbiome Project [9] arguably being most prominent.
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Metagenomic analysis does not come without its diffi-
culties; the molecular techniques used to generate the data
are not only challenging, but highly disparate, and there are
the additional issues associated with how best to manage,
store and analyse the huge data sets that are produced from
a metagenomics experiment [10]. Dealing with the infor-
matics challenges is important as they represent a new
problem when working with NGS due to the size and
complexity of the resultant data. This is especially perti-
nent to metagenomics where sequences of potentially
different species of unknown organisms may be being
detected and quantified. The informatics challenges are not
insurmountable though and considerable achievements
have been made to facilitate data analysis [11, 12]. How-
ever, while dealing with the challenges associated with
informatics is fundamental for metagenomic analysis, it
must not overshadow considerations around the more
common issues of technical accuracy and standardization.
Furthermore, the inclusion of control materials, be they
simpler standards for quality control or more complicated
reference materials, could provide a valuable tool for
understanding and tackling both the technical and the
informatics challenges. This leads to the question of how
such control materials should best support the different
approaches used for metagenomics analysis.
Different approaches
Any standard for metagenomic analysis will need to
account for the fact that there are different methods for
analysing complex microbial populations following nucleic
acid extraction. At the simplest dichotomy, mixed micro-
bial sequencing analysis can be performed by sequencing
either the whole metagenome or a targeted subset of it. The
simplest approach uses polymerase chain reaction (PCR) to
specifically amplify generic target sequences (sequences
shared between different microbes) like the bacterial 16S
ribosomal RNA gene (16S rDNA) [13]. The PCR products
(amplicons) are then sequenced (by an approach termed
amplicon sequencing) following their manipulation to
prepare them for sequencing (library preparation). Small
differences within the amplified deoxyribonucleic acid
(DNA) sequences are identified and compared to databases
of known sequences to determine which taxonomic groups
are present and with what relative abundance. This
approach can be very sensitive but is limited to the taxo-
nomic groups defined by the specificity of the PCR
primers; for example, the 16S ribosomal DNA gene is only
present within bacteria and so a PCR targeting the
sequence will not detect eukaryotic microbes or viruses.
Next generation sequencing can also be used to perform
a broader assessment of the microbial sequences present.
Applying NGS to whole metagenome sequencing allows
abundances of eukaryotic, bacterial, archaeal microbes as
well as viruses to be measured. A further level of com-
plexity will also be found by measuring ribonucleic acid
(RNA), as many viruses have RNA genomes (rather than
DNA). RNA may also be a useful proxy for microbial
viability. Furthermore, the types of RNA measured may
provide an idea of the metabolic challenges facing an
environment and assist in explaining why specific microbes
predominate in certain environments [14].
Whole metagenome sequencing requires fragmenting
the extracted genetic material, library preparation and
sequencing of the library fragments. Different NGS
instruments provide different data outputs with the current
trade-off being an inverse relationship between length and
number of sequences reads. The increased number of reads
will provide more sequence depth and therefore detect rare
sequences, while the longer reads will better facilitate the
building of the different microbial genomes present within
a sample which is useful when dealing with newly dis-
covered microbes for which reference sequences are
unavailable.
Considerations for developing control materials
for metagenomic analysis
There are a number of issues that require careful consid-
eration during the development of control materials for
metagenomic analysis such as whether they should com-
prise whole microbes or extracted nucleic acids. The ideal
control material would comprise whole microbes. This
would allow initial steps required to extract the nucleic
acid, as well as those for sequencing, to be controlled
during any measurement. The processes of nucleic acid
sampling, storage and extraction represent an important,
and usually neglected, source of error for molecular mea-
surement that must be considered when measuring
metagenomes [15]. However, developing control materials
to support this, while being the most desirable, presents
considerable challenges.
Assigning values based on whole microbes is not a
simple matter; classic microbial culture methods can be
used to estimate the number of colony forming units
(CFU). However, viable microbe number represents a
fundamentally different measure to nucleic acid quantity
and the two may or may not be correlated. Large batch
production of material offers alternatives, whether pro-
duction is achieved by mixing known amounts of microbes
or following the strategy used for matrix reference mate-
rials like water and soil or the world health organization
(WHO) clinical international standards [16]. For metage-
nomics, large batches of real clinical/environmental
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samples are arguably the most suitable controls. They do,
however, present challenges when considering character-
ization. Furthermore, there are additional problems of
ensuring comparable composition and traceability when
the material runs out and new batches are required, prob-
lems that will be accentuated by the complex nature
required from a metagenomic material.
Directing resources into developing, well defined, whole
microbial metagenomic materials would not only provide
valuable research tools, but the findings from such an
exercise would also inform the wider field of the impact of
the initial storage and extraction steps on a microbial-
profiling experiment. Yet, even with rigorous efforts, the
challenges associated with developing whole microbial
metagenomic materials are unlikely to be solved in the
immediate future. In the absence of whole microbial
materials, the availability of simpler process controls, to
investigate the specific issues, like those associated with
the sequencing steps, could offer considerable benefits. For
this reason, early stage materials for metagenomic analysis
are likely to comprise nucleic acid extracts, and the
remainder of this manuscript will focus on the production
of nucleic acid control materials. Types of nucleic acid
standards could range from complex environmental
extracts, mixes of cultured bacteria or synthetic genomes to
small fragments of DNA. Mixtures of cultured microbial
genomic DNA (gDNA) offer a simpler metagenomic
standard and this is what we and others have been inves-
tigating as potential control materials [9, 17].
Technical issues associated with microbial molecular
measurement, whether individual microbes or complex
communities, can be broadly split into measurement of
identity and of quantity. Sequence identity will facilitate
the grouping of an organism and depending on the ana-
lytical requirement can be down to species level or even
identifying different groups (strains) within a species. Fre-
quently, identity is required at the sub-strain level to
adequately consider specific genotypes at key genetic loci that
may afford resistance to therapies and thus are needed to guide
treatment. Microbial quantification requires not only some
degree of identity measure, but also estimation of the amount.
While quantifying/assigning relative proportions of the
component organisms and/or gene sequences is popular by
metagenomic studies [4, 7, 18–20], what has not been
addressed are estimations of technical confidence, or
uncertainty, with the importance of experimental design to
capture repeatability being highlighted in very prominent
journals [21]. To confound this, there are few commer-
cially available materials for metagenomic analysis
and actual gDNA reference materials are limited to indi-
vidual microbes [22]. Current methods for preparing
metagenomic control materials have relied on combin-
ing microbial gDNA extracts together that have been
quantified using classical optical methods [17] or using
quantitative molecular methods like real time PCR (qPCR)
[9]. While further work is required to describe how best to
prepare metagenomic control materials, it is already
becoming clear that they can offer a valuable tool (see
Fig. 1 and discussion below).
Additional considerations for reference materials
When considering the production of microbial genetic
reference materials to support both metagenomic analysis
and traceability, there are additional biological factors that
must be considered in addition to those applied to classical
chemical and physical reference materials. Not only is gDNA
a large macromolecule, it can also vary in size, complexity and
epigenetic status, offering hidden challenges when using
conventional methods for value assignment.
The simplest and most frequently used method for
quantifying bacterial gDNA is by estimating mass, usually
using absorbance or fluorescence [23]. Measurement of
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Fig. 1 Proportions of the MCM bacterial gDNA mixtures presented
as a pie chart based on estimation of mass and analysed using pre-
PCR and post-PCR protocols with assays 23 and 456. Klebsiella
pneumoniae and Streptococcus pneumoniae were not measured as a
predominant species when pre-PCR protocols are performed using
assay 23 and 456, respectively. This effect was less prominent when
post-PCR protocols were employed
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and susceptible to non-nucleic acid impurities. Fluores-
cence using double-stranded DNA-binding dyes like pico
green, while arguably more accurate than absorbance,
require comparison to a calibration curve of nucleic acid
that must have already been value assigned, thus leaving a
circular problem of how to value assign the calibrant.
Fluorescence has the additional problem of choice of cal-
ibrant; bacterial genomes are fairly large and complex
when compared to simpler plasmid and viral sequences that
are routinely used for fluorescence quantification, and it is
not clear how commutable a plasmid standard is for
accurate quantification of different bacterial gDNA.
Using gDNA mass, while simple, is not sufficient when
considering bacterial gDNA for metagenomics. Different
bacterial species and strains can have very different gen-
ome sizes. This means that gDNA mass is not a reliable
indicator of biomass or of number of cells. This will impact
on a metagenomic reference material (whether made from
physically mixed microbial DNA or an extracted environ-
mental sample) as the relative proportion of different bacterial
genomes by mass will be different from relative proportions of
the actual genome copies (Table 1). Consequently, when
quantifying or defining the relative proportion of bacterial
DNA, genome copy number must be considered and is argu-
ably the preferred measurand to DNA mass.
Estimation of number of bacterial genome copies is
further complicated by the fact that gDNA undergoes
complex patterns of chemical modification, such as meth-
ylation. These epigenetic modifications will alter the
molecular weight of the genome and therefore the number
of genome copies in a given mass. The extent of DNA
modification may vary among different species as well as
among individuals within a species. An additional issue
arises from the fact that bacterial gDNA materials are
usually made from extracts of bacteria that are replicating
their genomes during a logarithmic phase of growth. This
further complicates quantification because bacterial DNA
replication occurs in a bidirectional fashion from a single
point in the genome (the origin of replication). Consequently,
within a growing population of bacteria, genes that are
proximal to the origin of replication will be more abundant
than those that are more distal. This replication-associated
difference in gene dosage is well defined [24] and can be seen
by NGS analysis [25]. This makes value assignment by
enumeration more complicated and further reduces the suit-
ability of using mass alone as a traceable measurand for value
assigning reference materials containing bacterial gDNA.
For these reasons, production of a bacterial gDNA ref-
erence material would ideally incorporate some measure of
sequence homogeneity to account for batch to batch dif-
ferences in the abundance/dosage of different parts of the
genome in question. This and the epigenetic issues will
need to be considered when estimating the uncertainty
while value assigning microbial materials. Eukaryotic and
viral microbes can also contain epigenetic DNA modifi-
cations, and there will also be the potential for sequence
inhomogeneity, so some measure may also be needed to
factor this into any uncertainty estimation.
Ironically, as next generation sequencing technologies
improve, they may turn out to be the best methods to estimate
the impact of gene dosage and epigenetics on sequence inho-
mogeneity, thus proving crucial to understanding this increased
biological complexity and in turn reducing the uncertainties
applied to subsequent metagenomic reference materials. These
considerations are particularly important when considering
mixes of microbial genomes required to standardize metage-
nomic experiments because the impact of these biological
factors will differ between species and possibly between dif-
ferent preparations of the same species. However, while well-
described metagenomic reference materials are likely to be
valuable in the future, before any resources are channelled into
developing such a complex resource, we must consider what is
currently needed by the community.
What is needed?
Whether it was the intention of the initial experiment or
not, metagenomic studies frequently publish not only the
identities of the microbes present, but also offer some idea
of their relative proportions. This is typically presented as a
pie chart of the average proportion of organisms, or gene
types, with no information on experimental confidence, but
which offer the reader striking information highlighting the
most abundant group, or groups, of organism(s) (Fig. 1).
Table 1 Relative proportions (all values in %) of bacterial gDNA
used to make the metagenomic control material based on either mass,
gDNA copy number and 16S rDNA copies




MRSA 0.80 0.75 0.78
MSSA 12.00 11.52 11.96
S. pneumoniae 25.60 31.09 25.83
S. pyogenes 4.00 5.83 7.26
S. galactiae 1.50 1.87 2.72
E. faecalis 1.00 0.81 0.67
P. aeruginosa 1.00 0.43 0.36
K. pneumoniae 24.00 12.18 20.24
A. baumannii 0.10 0.07 0.07
E. coli 2.00 1.03 1.50
N. meningitidis 28.00 34.42 28.60
MRSA methicillin-resistant Staphylococcus aureus, MSSA methicil-
lin-sensitive Staphylococcus aureus
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Metagenomic control materials will allow laboratories to
test not only their experimental procedures for quantitative
bias, but also the precision associated with data and give an
idea of the error that the technique is providing within a
specific laboratory. This is a fundamental consideration to
any measurement and should not be neglected within the
field of metagenomics.
Initially, the uncertainty associated with metagenomic
control materials may not need to be very small. While
newer technologies, like digital PCR, are able to produce
small uncertainties on minute quantities of a specific piece
of DNA [26], current quantitative molecular measurement
of individual microbes in clinical scenarios rarely measures
changes of less than an order of magnitude and then only
with some kind of reference material if inter-laboratory
comparability is considered important [27]. Whether this
reflects a limitation of the technique that may be improved
on, or the true biological variation remains to be deter-
mined; however, the precisions of early metagenomic
measurements are unlikely to be any better. Consequently,
it may be favourable to produce metagenomics control
materials now, accepting that not all of the sources of error
have been pinned down yet. Such materials would,
unavoidably, have large associated uncertainties, and fur-
ther work is required to define the associated errors.
However, these materials could nevertheless be provided
with the specific aim of reducing the even larger errors that
are likely to occur as a result of numerous different labo-
ratories applying uncontrolled procedures using highly
disparate approaches.
Consequently, there is an arguable case for providers of
standards and reference materials to produce commercially
the types of process controls described below and else-
where [9, 17].
Example of the application of control materials
To investigate the development of a metagenomic control
material, we developed a mixed panel of gDNA from 11
different pathogenic bacteria (Table 1) (Detailed informa-
tion on the material preparation is available in the
Electronic Supplementary Material (ESM)). The bacterial
DNA was mixed at defined proportions based on mass;
then, we estimated genome copy numbers and numbers of
16S ribosomal gene copies (which can vary between dif-
ferent bacteria species and strains [28]) (ESM, Table 1).
This metagenomic control material (MCM) provided
approximately 3 orders of magnitude difference in the
abundance of the most concentrated gDNA (N. meningiti-
dis) compared to the least abundant (A. baumannii). The
concentrations were chosen to reflect an approximation
of what might be expected from a real clinical extract.
We prepared 300950 ll aliquots of the material in TE pH
7; material stability estimation at -20 and -80 C is
ongoing.
In our initial experiments, we used the MCM to compare
two amplicon sequencing protocols, with the MCM spiked
into 250 ng human gDNA (Promega). The Roche GS
Junior sequencing protocol requires the PCR amplicons to
have adapter sequences attached during library preparation.
These adapters can be added pre- (during primer synthesis)
or post- (using ligation) PCR. This experiment investigated
how the two approaches differed when measuring the
MCM. Both amplicon sequencing protocols used the same
two PCR assays to amplify different parts of the bacterial
16S rDNA gene (either variable regions 2 and 3 [assay 23]
or variable regions 4, 5 and 6 [assay 456], details in ESM
Table 2). Primer sets were designed to bind the conserved
regions of the 16S rDNA gene but were selected to not
complement perfectly with all 10 MCM species (Table 2).
Primer mismatches against specific bacterial species are
common when performing 16S analysis as the conserved
regions are not perfectly conserved. Such mismatches can
impact on the efficiency of the PCR and thus on quantifi-
cation of individual bacterial gDNA [29].
This experiment aimed to investigate whether the MCM
was of value when comparing the use of different amplicon
sequencing approaches and for informing whether species-
specific primer mismatches could cause measurement
issues for metagenomic analysis. Following the respective
emulsion PCR, the amplicons were sequenced according to
the Roche GS Junior sequencing protocol. Sequence data
were analysed using megaBLAST [30] against a custom
database of 16S rDNA sequences comprising the 16S
rDNA sequences from the ten species included in the
MCM. We then used MEGAN [31] to assign sequence
reads to bacterial taxa and to infer relative abundances of
each sequenced species.
Figure 1 presents the results from different amplicon
sequencing approaches using two different PCR assays.
The two approaches provide different results with both
assays demonstrating better agreement with the initial
mass-based estimation of the MCM composition when
adapters were ligated onto the amplicon post-PCR. We
observed that where the results underestimate the abun-
dance of specific bacteria (compared to the mass-based
method) corresponded to where a sequence mismatch
occurred (Table 2). This was particularly apparent when
presenting data using the pie chart format commonly found
in metagenomic publications; when applying the adapters
post-PCR, the magnitudes of the predominant organisms
differ from the mass-based estimation, but the actual pre-
dominant organisms remain the same. When adapters were
applied pre-PCR, the predominant organisms change
depending on which assay is used.
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The result from this preliminary experiment suggests
that amplicon sequencing can differ in its estimation of the
abundance of specific bacteria in a metagenomic sample
that this can be dependent on choice of assay and appears
to be linked to respective sequence mismatches within
conserved regions (Table 2). Furthermore, these differ-
ences were more pronounced when the sequencing adapters
were incorporated onto the primers prior to the PCR sug-
gesting primers which also contain adapter maybe more
susceptible to the biases observed. The use of control
materials like the LGC MCM demonstrate that findings can
differ considerably depending on how the initial experi-
ment is set up and illustrates that they provide a valuable
tool for assay development.
While these types of standards have not been exten-
sively used yet, they represent the only means by which
technical problems, like those highlighted by Fig. 1, can be
identified. Thus, there is a clear need for the availability of
carefully prepared and defined materials. This is crucial to
facilitate the development of metagenomics capacity in
laboratories planning to start performing such analysis and
to standardize the measurements between different labo-
ratories performing existing analysis.
Conclusion
Metagenomics offers huge potential to revolutionize our
understanding of the microbial world. With the explosion
in different high-capacity methodologies to investigate
metagenomes, considerable thought is needed to ensure
both informatics analysis and initial experimental design
are performed using methods that allow inter-experimental
comparability. Furthermore, it is vital that the issues
associated with metagenomic analysis highlighted here are
considered. This is because if results being reported are
unrepresentative of reality due to technical biases, our early
understanding of the microbiome may be misrepresented.
These challenges may not be insurmountable, however,
and our early findings suggest that the use of nucleic acid-
based materials as process controls could offer a valuable tool
for developing metagenomic capacity although it is likely that
controls that contain mixes of whole microbes are what will
eventually be required. Accurate and comparable metage-
nomic approaches will facilitate the maximum impact of
associated research, ensuring that our understanding of the
microbial world in the context of the environment and human
health is not misguided by technical bias.
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